We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.20 | 3.23% | 6.40 | 5.80 | 6.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 6.37 | 6.10 | 6.15 | 266,658 | 16:35:17 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 55.2M | -40.22M | -0.0084 | -7.32 | 295.52M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/12/2024 | 13:41 | UK RNS | Allergy Therapeutics PLC Exercise of Options and Total Voting Rights |
| 17/12/2024 | 16:19 | UK RNS | Allergy Therapeutics PLC Block Listing Interim Review |
| 16/12/2024 | 15:33 | UK RNS | Allergy Therapeutics PLC Result of Annual General Meeting |
| 04/12/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Positive Interim Data from PROTECT Trial |
| 27/11/2024 | 16:52 | ALNC |  IN BRIEF: Allergy Therapeutics treats first patient in allergy trial |
| 27/11/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC First Patient Dosed in G308 Paediatric Trial |
| 25/11/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Submission of MAA for Grass MATA MPL |
| 21/11/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Notice of 2024 Annual General Meeting |
| 06/11/2024 | 11:22 | ALNC | Allergy Therapeutics annual loss narrows thanks to reduced expenses |
| 06/11/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Audited Preliminary Results 2024 |
1 Year Allergy Therapeutics Chart |
Intraday Allergy Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
